Green Alpha Advisors’s bluebird bio BLUE Stock Holding History

Green Alpha Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-733	Closed	-$71K	–	150
2022 Q1	$71K	Buy	733 +89	+14%	+$11.7K	0.05%	136
2021 Q4	$129K	Sell	644 -327	-34%	-$77.2K	0.09%	122
2021 Q3	$240K	Buy	971 +265	+38%	+$75.8K	0.17%	125
2021 Q2	$292K	Buy	706 +137	+24%	+$54.3K	0.2%	123
2021 Q1	$222K	Buy	+569	New	+$280K	0.22%	107

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Green Alpha Advisors's BLUE Position: Q2 2022 in Review

Green Alpha Advisors sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 733 shares — an estimated $71K sold.

Green Alpha Advisors first reported a position in BLUE in Q1 2021 and held it in 5 quarters. The position peaked at $292K in Q2 2021. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

Green Alpha Advisors reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
Green Alpha Advisors sold 733 bluebird bio shares in Q2 2022, an estimated $71K.
Green Alpha Advisors first reported a position in bluebird bio in Q1 2021 and held it in 5 quarters.
Green Alpha Advisors's bluebird bio position peaked at $292K in Q2 2021.
151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Green Alpha Advisors's 13F filing for Q2 2022, filed 8 Jul 2022.